|Articles|August 1, 2013
- Applied Clinical Trials-08-01-2013
- Volume 22
- Issue 8
ACT Insert Cover
S
Advertisement
Cover
Articles in this issue
about 13 years ago
Looking Further Into Transparencyabout 13 years ago
The Practical Implementation of Risk-Based Monitoringabout 13 years ago
Guidance and Strategies for Spurring Development of New Therapiesabout 13 years ago
RBM in Late Phaseabout 13 years ago
Paperless Clinical Trial Optimization—Thinking Outside the Boxabout 13 years ago
Controversy Grows Over How Best to Share Dataabout 13 years ago
SOPs in Clinical Researchabout 13 years ago
Comprehensive Evidence Development: Progress and Opportunitiesabout 13 years ago
Risk-Based Approachesabout 13 years ago
Impact on the FutureAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief: Data Quality as Foundational to Trial Modernization, CRAs Evolving to Strategic Site Partners, and 2026 Emerging Pharma Leaders Announced
2
ACT Brief: Training Completion Versus Execution Readiness, AI Monitoring Agent Financial Value at Scale, and FDA Warning Letters and AI Oversight Gaps
3
Closing the Dead Time Gap in Clinical Data: Q&A with Raviv Pryluk, PhaseV
4
Survey Finds US Biotechs Prefer Domestic First-in-Human Trials but FDA Hurdles Are Pushing Them Abroad
5